ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $21,807,000 | -44.9% | 2,211,622 | -39.4% | 0.65% | -44.6% |
| Q4 2020 | $39,566,000 | +39.7% | 3,650,000 | +32.7% | 1.17% | -7.6% |
| Q3 2020 | $28,325,000 | -27.3% | 2,750,000 | +47.5% | 1.27% | -45.0% |
| Q2 2020 | $38,941,000 | +254.3% | 1,865,000 | +65.8% | 2.30% | +97.5% |
| Q1 2020 | $10,991,000 | +531.7% | 1,125,000 | +275.0% | 1.17% | +281.4% |
| Q1 2018 | $1,740,000 | +53.4% | 300,000 | -28.6% | 0.31% | -54.3% |
| Q1 2017 | $1,134,000 | – | 420,000 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,102,735 | $3,485,000 | 3.61% |
| VHCP Management II, LLC | 280,000 | $885,000 | 0.53% |
| GREAT POINT PARTNERS LLC | 550,116 | $1,738,000 | 0.50% |
| JW Asset Management, LLC | 189,919 | $600,000 | 0.48% |
| DAFNA Capital Management LLC | 140,600 | $444,000 | 0.35% |
| Granite Point Capital Management, L.P. | 186,544 | $589,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 779,926 | $2,465,000 | 0.13% |
| TFS CAPITAL LLC | 159,364 | $504,000 | 0.09% |
| Rhenman & Partners Asset Management AB | 154,006 | $487,000 | 0.09% |
| Numeric Investors LLC | 1,134,931 | $3,586,000 | 0.03% |